Medical Health Encyclopedia

Drug-induced lupus erythematosus


InjuryDiseasesNutritionPoison
SymptomsSurgeryTestSpecial Topic
Antibodies
Lupus, discoid on a child's face
Lupus, discoid on a child's face
Lupus, discoid on the face
Lupus, discoid on the face
Lupus, discoid  - view of lesions on the chest
Lupus, discoid - view of lesions on the chest
Overview Symptoms Treatment Prevention
Treatment

Usually, symptoms go away within several days to weeks after stopping the medication that caused the condition.

Treatment may include:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) to treat arthritis and pleurisy
  • Corticosteroid creams to treat skin rashes
  • Antimalarial drugs (hydroxychloroquine) to treat skin and arthritis symptoms

Very rarely, high doses of corticosteroids (prednisone, methylprednisolone) and immune system suppressants (azathioprine or cyclophosphamide) are used to treat persons with severe drug-induced lupus that affects the heart, kidney, and neurological system.

Protective clothing, sunglasses, and sunscreen are recommended.





Support Groups


Expectations (prognosis)

Drug-induced lupus erythematosus is usually not as severe as SLE. Usually, the symptoms go away within a few days to weeks after stopping the medication.

You should avoid the medication in the future, or symptoms usually return. Routine eye exams are recommended to detect eye complications early.


Complications

Calling your health care provider

Call for an appointment with your health care provider if:

  • Your symptoms do not improve after you stop taking the medication that caused the condition
  • You develop new symptoms


Review Date: 05/31/2009
Reviewed By: Mark James Borigini, Associate Clinical Professor of Medicine, University of California, Irvine, Irvine, CA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org).

Find a Therapist
PR Newswire